× Try our new beta.tvnews.vanderbilt.edu website, for new pricing, more content, and immediate delivery of loans.
Search the Archive

Commercial: Neulasta Onpro #1172037

CBS Evening News for Monday, May 23, 2016
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

The day after chemo you could be home with your support system. Here here and here with you last hour on proud strong chemo can put you at risk for infection in a key study Neulasta Onpro reduce the risk of infection from 17 percent to 1 percent. A 94 percent decrease apply the day of chemo new last on pros designed to automatically deliver Neulasta the next day without returning to the doctor just for a new last shot. The last is for certain cancer patients receiving strong chemotherapy do not ...
Duration:
00:00:56

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.